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Summary: A high performance liquid chromatography (HPLC) method was developed for the quantitation of
strychnine in urine of children with noiiketotic hyperglycinaemia and other developmental disorders treated with the
alkaloid. Mobile and stationary phases were polar, i.e. methanol-water-330 g/kg ammonia (volumes, 85 ml +
14.2 ml + 0.8 ml) and LiGhrosorb Si-60,7 . Brucine was the internal Standard. Extraction was perfbrmed by the
Extrelut technique. At strychnine nitrate concentrations in urine of 21,126, and 760 g/l, recovery was 92.1 ± 8.7,
98.1 ± 2.7, and 102.5 ± 2.7%. A child with nonketotic hyperglycinaemia under continued strychnine treatment
excreted l to 13.6% of the daily dose unmetabolized in urine. The method was also suitable for the estimation of
unreacted strychnine in tissue extracts. The fast disappearance in vitro of strychnine from a guinea pig liver prepara-
tion was confirmed.
Eine neue Methode für die quantitative Bestimmung von Strychnin in Harn und Gewebsextrakten
mit Hochleistungsflüssigkeitschromatographie (HPLC)
Zusammenfassung: Zur Bestimmung von Strychnin im Harn von Kindern mit nicht-ketotischer Hyperglycinämie und
anderen Entwicklungsstörungen, die mit dem Alkaloid behandelt werden, wurde eine Methode unter Verwendung der
Hochleistungsflüssigkeitschromatographie (HPLC) entwickelt. Mobile und stationäre Phase waren polar, es wurden
Methanol/Wasser/330 g/kg Ammoniak (Volumina, 85 ml + 14,2 ml + 0,8 ml) und LiChrosorb Si-60, 7 , verwen-
det. Brucin diente als innerer Standard. Die Extraktion würde mit der Extrelut-Technik durchgeführt. Die Wiederfin-
dung für Strychninnitrat-Konzentrationen im Harn von 21,126 und 760 /zg/1 betrug 92,1 ± 8,7, 98,1 ± 2,7 und
102,5 ±2,7%. Ein Kind mit nicht-ketotischer Hypergjycinäinie schied unter kontinuierlicher Strychninbehandlung
1—13,6% der täglichen Dosis unverändert im Harn aus. Die Methode erwies sich ebenso als geeignet für die Bestim-
mung von unverändertem Strychnin in Gewebsextrakten. Das schnelle Verschwinden von Strychnin aus einer Meer-
schweincherdeber-Präparation in vitro wurde bestätigt.
Introduction
Strychnine has a long history äs a spinal analeptic but
little is known of its metabolism. If given in repeated
toxic doses to cats, dogs and guinea pigs, only a small
amount is excreted in biologically active form in the
urine, all of it within 24 h after the last dose (1). Un-
reacted strychnine is found in most tissues of cats and
dogs and it is concentrated 6—7 fold in liver and kidney
(2). In värious animal species, the bulk of the drug is
metabolized in the liver (3,4), and it is not metabolized
in gut, muscle, heart, kidney, brain or blood (4). In
vitro transformation of strychnine by rabbit liver, meas-
ured with the methyl orange reaction, was apparently
enzymatic; it occurred in microsomes enriched with
soluble fraction, required O2 and NADPH, and had a
narrow pH Optimum gt 8.4 (4). Phenobarbital and other
inducing compounds given to rats and rabbits enhanced
strychnine metabolism and lowered sensitivity (5, 6).
Male rats had higher tolerance to strychnine than females
(7). Of at least 4 metabolites produced by rabbit liver
homogenates, only one was identified äs 2-hydroxy-
stiychnine which in mice had a toxicity of only one
hundredth of the parent alkaloid (6). Glucuronidation
and sulfatation played only a minor role, if any, in the
detoxification of strychnine by rabbit microsomes (4).
A few years ago, we initiated the treatment of children
with nonketotic hyperglycinaemia and other develop-
mental disorders with pharmacological doses of strych-
nine (8-11). Thus there arose the need to measure un-
reacted strychnine in urine and other biological fluids.
Colour reactions (12), measurement of absorbance at
one or two wavelengths after Separation (13—15),
double labeling techniques (16), GLC Separation (17),
and existing HPLC methods for grain baits (18) and drug
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mixtures (19, 20) were unsatisfactory in one or more
respects. The interesting reversed phase HPLC method
oiCrouch &Short (21) did not separate strychnine
from brucine except by use of a solvent gradient. We
developed a HPLC method which differs from the
above (21) by making use of polar stationary and
mobile phases and an isocratic solvent with brucine äs
the internal Standard. Here we describe 'the procedure
and its first applications.
Materials and Methods
Strychnine nitrate Ph. Helv. VI (Siegfried, Zofmgen, Switzer-
land) (Mr free strychnine 334.4; ,. strychnine nitrate 397.4);
brucine · 2H2O p.a. (MT free brucine 394.4;MT brucine ·
2H2O 430.4), aqueous ammonia 33% (d - 0.885), hexane p.a.,
and tetrahydrofuran Uvasol (Merck, Darmstadt, F.R.G.).
Extrelut® for column extraction (Merck, F.R.G.). Equipment
for HPLC: pump Altex 100 (Altex Scientific Inc., Berkeley Ca.,
USA), injector UGK and detector at 254 nm model 440
(Waters Associates Inc., Milford Ma., USA). HPLC column
(46 X 250 mm) and precolumn (4.6 X 40 mm) were packed
with LiChrosorb Si-60, 7 (Knauer, Berlin F.R.G.), the
stationary phase. The mobile phase was methanol-water-330 g/kg
ammonia (volumes,, §5 ml + 14.2 ml + 0.8 ml).
Extraction
A sample of 4 ml urine was spiked with 100 internal Standard
solution (brucine · 2H2O, 20 mg/1 in methanol), adjusted to
pH 12.0 with 3 mol/1 NaOH and applied to a column (9 cm X
2.5 cm) containing 4 g Extrelut. The sample was allowed to
equilibrate with the Extrelut for 10 min. Substances were
eluted with 50 ml dichloromethane and the total eluate was
evaporated to dryness in vacuo. The residue was dissolved in
2 X 0.5 ml methanol, transfered to a small test tube and the
methanol evaporated in a stream of nitrogen.
Chromatography
For HPLC the residue was dissolved in 50 of mobile phase,
and 1-5 were injected. The flow rate was 2.0 ml/min. The
elution was monitored at 254 nm with a detector sensitivity of
0.005 absorbance units on the füll scale and a recorder sensitivity
of 5 mV. The column was not stored in the mobile phase which
was polar and basic. Instead, the column was rinsed with
approx. 30 ml of tetrahydrofuran followed by hexane äs an
inert solvent for storage. Before it was reused, the column was
rinsed with at least 10 ml of tetrahydrofuran followed by the
mobile phase. By this treatment, the column was kept clean
and could be used successfully and extensively for at least two
months. The small dead volume which appeared at the top of
the column bed after several months of use was fiUed with
Li-Chrosorb Si-60 and the column employed further. (Theoreti-
caily one could avoid the formation of a dead volume by insert-
ing a silica gel precolumn between pump and injector).
Calculation
The concentration of strychnine in the sample was calculated
using the formula:
cstrychnine = R · F · Cbrucine · 2H2O
where R was the peak height ratio, strychnine to brucine, at
254 nm. Factor F was determined previously using the Standard
substances:
p = — . Cst|tychnine
cbrucine ·
Under our conditions it was 0.40 for free strychnine.
Results and Discussion
Extraction and quantitation of strychnine
For extraction of urines, solvente with higher polarity
such äs dichloromethane-isopropänöl (volumes, 90 ml
+ 10 ml) or ethyl-acetate offered the advantage of
smaller volumes, but they resulted in t^ilings of UV
absorbance ("solvent peaks"), which interfered with
the strychnine peak. With tölüene or benzene äs the
extraction solvents, the biological background was al-
most nil büt brucine recovery was variable. The Extrelüt
technique (22) provided for excellent recovery and low
biological background. High urinary salt concentrations
(up to 0.3 mol/1 sodium Chloride added) did not impair
the extraction.
For high performance liquid chrornatography, several
solvents were tried äs mobile phases, e.g. diethylether?
methanol-diethylamine (20) and dichloromethane-
methanol-diethylamine mixtures. With methanol-H20-
330 g/kg ammonia (volumes, 85 ml + 14.2 ml + 0.8 ml),
optimal resolution and the clearest bäekgfound were
obtained (number of theöreticäl plätes 900^1200).
Several unspiked urines from healthy children and adults
were processed, and peaks interfering with the position
of strychnine and brucine were not observed (fig, Ib).
In order to evahiate the precision of the niethod, stryeh-
nine nitrate was added to a urine specimen of a contfol
persöri at a concentration of 220 /l, and 4 ml portions
were processed. The Variation coefficient (VC) was
0.8% (n =12).
A linear calibration curve was obtaüied by the additiqn
of strychnine nitrate to üririe tö yield cönceritratiorls öf
20-840 jug/1 (coefficient of cofrelation r = 0.999;
n = 12). The calibration curve matched the curves ob-
tained from pure Standards.
Recovery was tested by the addition of strychnine
nitrate to coiitrol urines of 6 children at low (21 ,/ig/l),
intermediate (126 Mg/1) and high (760 Mg/1) concentra-
tions. Recovery was 92.1 ± 8.7, 98.1 ± 2.7, and 102.5 ±
2.7%,respectively.
The detection iimit was 2-4 ng per injection; starting
with a 4 ml urine sample, this corresppnded to a strych-
nine coricenträtion of 5—10 %/1. When the ürinäry
strychnine concentration exceeded 200 mg/1, sample
size could be reduced.
Strychnine metäbolites were not investigated in pur
study. It can be expected that they will not interfeje
with the measurement of stfychnine. "Becäüse of their
different polarity and mölecular weight, they will either
not be extracted or be separated from strychnine
chromatographically.
a
Application of the method
Chromatograms of stiychnine extracted from the urine
of a child treated with the alkaloid aiid from a spiked
1. Clin. Chem. Cün. Biochem. / Vol. 20,1982 / Nq. 4
Egloff et al.: Quantitation of strychnine in urine and tissue extracts 205
0.002 -
Strychnine
Brucine
0.001 -
i [min]
Fig. 1. HPLC of strychnine in human urine (a, b) and in guinea pig liver extract (c).
Brucine - 2 Η2Ο (500 Mg/1) was the internal Standard. Column (46 X 250 mm) and pre-column (4.6 X 40 mm) of LiChrosorb
Si-60, 7 μηι; mobile phase methanol-water-330 g/kg ammonia (volumes, 85 ml + 14.2 ml + 0.8 ml);flow rate 2 ml/min
a) Urine of patient B.F.; injected volume: 3 μΐ of extract, equivalent to 0.24 ml of urine.
b) Urine of a healthy control person without strychnine (otherwise same s a).
c) Supernatant of guinea pig liver extract after incubation; injected volume: 4 μΐ of extract, equivalent to 0.32 ml of diluted
mixture (see fig. 2).
control urine are shown in figures l a and Ib. Patient
B.F. (8) suffering from nonketotic hyperglycinaemia
and treated with daily oral strychnine nitrate for 3
years excreted from l to 13.5% of the drug unmeta-
bolized (tab. 1). There was no correlation between the
Proportion of unmetabolized strychnine in urine arid
the duration of therapy or the administered dose. It is
interesting that these results were in good agreement
with those obtained many years ago in man (3) and in
animals (1).
The method was also applied to tissue extracts (fig. Ic).
An experiment published byAdamson &Fouts (4) was
Tab. 1. Excretion of strychnine in 24 h urine of patient B. F.
with nonketotic hyperglycinaemia (8) during continued
treatment with oral strychnine nitrate.
Age
(a)
6/12
7/12
7/12
8/12
3
3K
Weight
(kg)
7.5
7.8
8.0
8.9
11.5
12.1
Doseof
strychnine
nitrate
(rng/d)
1.2
3.2
1.8
3.0
12.8
12.8
Strychnine *
excreted
(Mg/24 h)
18.9
*19.9
29.3 ·
*23.7
26.3
*18.3
116.3
*112.0
335.0
1475.0
Percent of
administered
strychnine in
24 hrurine
o
1.0
1.5
4.6
3.1
13.6
Values obtained from a second extraction and chromato-
graphy done after the samples had been kept at - 20 °C for
lyear.
duplicated and the disappearance of unreacted strych-
nine in a guinea pig liver microsome preparation fol-
lowed (fig. 2). Strychnine concentration feil in a first
order mode to one tenth of the initial concentration at
a rapid rate (50% disappearance in 16 min). The suit-
ability of the method for the quantitation of strychnine
in tissue extracts was thus est blished.
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Fig. 2. Metabolism of strychnine by guinea pig liver microsomal
preparation in vitro.
Supernatant, 9000 g, from 1.2 g of liver (l :4 homogenate
in 0.15 mol/i KC1) was incubated at 37 °C in a Warburg
apparatus under oxygen with 12 Mmoles of strychnine
nitrate in 0.12 mol/1 fris-HCl pH 8.2. Initial concentra-
tions of cofactors were: nicotinaniide 40 mmol/1, NADP
55 μηιοΐ/ΐ, glucose-6-phosphate 5 mmol/1. Volume was
12 ml. At the times indicated, 0.6 ml aliquots were with·
drawn, denatured for 2 min at 100 °C, centrifuged, diluted
with water 800 times, and 4 ml of diluted mixture were
processed for strychnine extraction and Chromatograph}'.
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